Fatty acid-binding protein 4 is associated with endothelial dysfunction in patients with type 2 diabetes

Atherosclerosis

Volumn 213, Issue 1, 2010, Pages 329-331

  Aragonès, Gemma ^a   Ferré, Raimon ^a   Lázaro, Iolanda ^a   Cabré, Anna ^a   Plana, Núria ^a   Merino, Jordi ^a   Heras, Mercedes ^a   Girona, Josefa ^a   Masana, Lluís ^a  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

Cardiovascular risk; Endothelial function; FABP4; Inflammatory markers; Oxidative markers; Reactive hyperemia; Type 2 diabetes

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FATTY ACID BINDING PROTEIN 4; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR RISK; CAROTID ARTERY; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPEREMIA; IMAGING SYSTEM; INFLAMMATION; INTIMA; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION; PRIORITY JOURNAL; TUNICA MEDIA; ULTRASOUND;

ADULT; AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; HYPEREMIA; INFLAMMATION; MALE; MIDDLE AGED; OXYGEN; REGRESSION ANALYSIS; RISK;

EID: 77958481105     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.07.026     Document Type: Article

References (15)

1. Makowski L., Boord J.B., Maeda K., et al. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med 2001, 7:699-705.
2. Elmasri H., Karaaslan C., Teper Y., et al. Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells. FASEB J 2009, 23:3865-3873.
3. Fu Y., Luo L., Luo N., Garvey W.T. Lipid metabolism mediated by adipocyte lipid binding protein (ALBP/aP2) gene expression in human THP-1 macrophages. Atherosclerosis 2006, 188:102-111.
4. Makowski L., Brittingham K.C., Reynolds J.M., Suttles J., Hotamisligil G.S. The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities. J Biol Chem 2005, 280:12888-12895.
5. Cabre A., Lazaro I., Cofan M., et al. FABP4 plasma levels are increased in familial combined hyperlipidemia. J Lipid Res 2009.
6. Cabre A., Lazaro I., Girona J., et al. Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients. Atherosclerosis 2007, 195:e150-e158.
7. Cabre A., Lazaro I., Girona J., et al. Plasma fatty acid-binding protein 4 increases with renal dysfunction in type 2 diabetic patients without microalbuminuria. Clin Chem 2008, 54:181-187.
8. Cabre A., Lazaro I., Girona J., et al. Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes. J Lipid Res 2008, 49:1746-1751.
9. Coll B., Cabre A., Alonso-Villaverde C., et al. The fatty acid binding protein-4 (FABP4) is a strong biomarker of metabolic syndrome and lipodystrophy in HIV-infected patients. Atherosclerosis 2008, 199:147-153.
10. Yeung D.C., Xu A., Cheung C.W., et al. Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis. Arterioscler Thromb Vasc Biol 2007, 27:1796-1802.
11. Lamounier-Zepter V., Look C., Alvarez J., et al. Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease. Circ Res 2009, 105:326-334.
12. Jansson P.A. Endothelial dysfunction in insulin resistance and type 2 diabetes. J Intern Med 2007, 262:173-183.
13. Ter Avest E., Stalenhoef A.F., de Graaf J. What is the role of non-invasive measurements of atherosclerosis in individual cardiovascular risk prediction?. Clin Sci (Lond) 2007, 112:507-516.
14. Miyoshi T., Onoue G., Hirohata A., et al. Serum adipocyte fatty acid-binding protein is independently associated with coronary atherosclerotic burden measured by intravascular ultrasound. Atherosclerosis 2010, 211:164-169.
15. Rhee E.J., Lee W.Y., Park C.Y., et al. The association of serum adipocyte fatty acid-binding protein with coronary artery disease in Korean adults. Eur J Endocrinol 2009, 160:165-172.